VHL and pancreatic neuroendocrine tumor: On the other hand, mutations in the von Hippel–Lindau (VHL) gene are associated with SCNs, and mutations in the multiple endocrine neoplasia 1 (MEN1) gene or loss of heterozygosity (LOH) are associated with pancreatic neuroendocrine tumors [49].